HC Wainwright Weighs in on Core Scientific Q1 Earnings

Core Scientific, Inc. (NASDAQ:CORZ) – Analysts at HC Wainwright issued their Q1 2025 earnings estimates for Core Scientific in a research report issued to clients and investors on Thursday, February 27th. HC Wainwright analyst K. Dede expects that the company will earn ($0.07) per share for the quarter. HC Wainwright has a “Buy” rating and a $17.00 price objective on the stock. The consensus estimate for Core Scientific’s current full-year earnings is $0.52 per share. HC Wainwright also issued estimates for Core Scientific’s Q2 2025 earnings at ($0.10) EPS, Q3 2025 earnings at ($0.10) EPS, Q4 2025 earnings at ($0.11) EPS and FY2025 earnings at ($0.38) EPS.

Several other research analysts have also recently weighed in on CORZ. Roth Mkm began coverage on shares of Core Scientific in a report on Friday, November 15th. They set a “buy” rating and a $25.50 price target on the stock. Cantor Fitzgerald reduced their target price on Core Scientific from $24.00 to $21.00 and set an “overweight” rating for the company in a report on Thursday, February 27th. Macquarie upped their price objective on Core Scientific from $16.00 to $19.00 and gave the company an “outperform” rating in a research note on Thursday, November 14th. BTIG Research lifted their target price on Core Scientific from $19.00 to $20.00 and gave the stock a “buy” rating in a research note on Monday, December 16th. Finally, Craig Hallum started coverage on shares of Core Scientific in a research report on Tuesday, January 21st. They set a “buy” rating and a $24.00 price target for the company. Fifteen investment analysts have rated the stock with a buy rating and one has assigned a strong buy rating to the stock. Based on data from MarketBeat, the company has an average rating of “Buy” and an average target price of $19.07.

Core Scientific Stock Down 9.1 %

Shares of NASDAQ:CORZ opened at $10.14 on Monday. The business’s 50 day moving average is $13.12 and its 200 day moving average is $13.34. Core Scientific has a 12-month low of $2.61 and a 12-month high of $18.63. The stock has a market cap of $2.83 billion and a price-to-earnings ratio of -1.87.

Core Scientific (NASDAQ:CORZ) last released its quarterly earnings results on Wednesday, February 26th. The company reported ($0.01) earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of ($0.10) by $0.09. The company had revenue of $94.93 million for the quarter, compared to analyst estimates of $97.07 million.

Institutional Inflows and Outflows

Several institutional investors have recently modified their holdings of CORZ. Vanguard Group Inc. raised its position in shares of Core Scientific by 54.3% during the 4th quarter. Vanguard Group Inc. now owns 19,378,652 shares of the company’s stock valued at $272,270,000 after buying an additional 6,819,406 shares in the last quarter. Beryl Capital Management LLC raised its position in Core Scientific by 24.3% during the fourth quarter. Beryl Capital Management LLC now owns 18,179,586 shares of the company’s stock valued at $255,423,000 after purchasing an additional 3,548,396 shares in the last quarter. Driehaus Capital Management LLC lifted its stake in Core Scientific by 112.1% during the fourth quarter. Driehaus Capital Management LLC now owns 10,264,204 shares of the company’s stock worth $144,212,000 after purchasing an additional 5,424,901 shares during the last quarter. ORG Wealth Partners LLC boosted its holdings in shares of Core Scientific by 0.3% in the 4th quarter. ORG Wealth Partners LLC now owns 8,986,651 shares of the company’s stock worth $126,262,000 after purchasing an additional 26,649 shares in the last quarter. Finally, FMR LLC increased its position in shares of Core Scientific by 2,937.7% during the 4th quarter. FMR LLC now owns 7,436,229 shares of the company’s stock valued at $104,479,000 after purchasing an additional 7,191,428 shares during the last quarter.

Insider Activity

In other news, insider Todd M. Duchene sold 129,861 shares of the business’s stock in a transaction on Thursday, January 2nd. The shares were sold at an average price of $14.24, for a total transaction of $1,849,220.64. Following the completion of the transaction, the insider now directly owns 2,051,649 shares in the company, valued at $29,215,481.76. The trade was a 5.95 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CEO Adam Taylor Sullivan sold 369,712 shares of the stock in a transaction on Friday, January 24th. The stock was sold at an average price of $16.24, for a total value of $6,004,122.88. Following the completion of the sale, the chief executive officer now owns 3,758,793 shares in the company, valued at $61,042,798.32. This trade represents a 8.96 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 614,032 shares of company stock worth $9,534,916. 32.00% of the stock is owned by company insiders.

Core Scientific Company Profile

Core Scientific, Inc provides digital asset mining services in North America. It operates through two segments, Mining and Hosting. The company offers blockchain infrastructure, software solutions, and services; and operates data center mining facilities. It also mines digital assets for its own account; and provides hosting services for other large bitcoin miners, which include deployment, monitoring, trouble shooting, optimization, and maintenance of its customers' digital asset mining equipment.